Trump to unveiled Medicare medication prize after he teased “shaking earth” announcement

The great announcement that President Trump was annoyed in the Oval Office at the beginning of this week is a “most preferred nation” plan to reduce medication prices, said sources CBS News.

The Trump administration previously tried to implement the idea of ​​the “most preferred nation” during the first term of office and to bind some inexpensive medication with medication that was administered by healthcare service providers at “the lowest price that medicinal manufacturer in other countries received”.

Trump said on Tuesday in the Oval Office that he would reveal “a really shaken and positive development for this country and for people in this country in the coming days.

The spokesman for the White House rejected a statement. Health and human services did not react immediately to a request for comments.

Court commands of the drug industry and others blocked the centers for Medicare and Medicaid services to implement the proposal in Mr. Trump's first term, and explained that the government had not carried out the proper steps for creating and implementing the end 2020.

“Although it is not illegal in the last few days of a presidential administration to rush to politics (in fact it is a time -honored tradition), the executive officers must not avoid the clear legal requirements in the eleventh hour in order to achieve goals that they could not achieve in the normal course,” a federal judge in California decided in California 2020.

The bidges administration gave up the proposal in 2022 and responsible for court commands that blocked the model and concerns of the stakeholders, including the fears that some Medicare beneficiaries could cut off by drugs and regular providers.

Robert F. Kennedy Jr., secretary for Mr. Trump's health and human services, indicated the possibility of returning politics on Tuesday, which indicates higher prices in Europe for the Blockbuster -Diabetes drug -Ozempic. The drug is also used for weight loss under another brand name Wegovy.

“At the moment the big obstacle is really a price. And we negotiate the pharmaceutical companies and see if we can at least start a few pilot programs or whether we can make the price low enough, we can provide it for all state costs,” he said in an interview with Newsmax.

Kennedy defended a decision by the Trump administration last month Not to cover weight loss medication in Medicare and Medicaid, with a proposal to be advertised by the bidding. The Trump government continues to negotiate the costs From ozempic In Medicare under discussions that were launched by the bidges, but only for his use for the treatment of diabetes and other health conditions.

While drugs like Ozempic are “miracle drugs in many ways”, Kennedy warned that their costs are unaffordable.

“If we do it in such a way that Medicaid, Medicare paid for it and that private insurance companies had to pay for it, we would double the costs of health insurance for most employers in this country. And that would be really destructive,” he said.

Politico previously reported that Mr. Trump would lead the helpers to reintroduce the drug pricing plan, which he wanted during his first term.